Interleukin-6 from blood-forming stem cells may sustain organ damage while preserving defense
Aging blood-forming stem cells may sustain damage by secreting interleukin-6 while their descendants retain antimicrobial memory. Insufficient secretion, or damage declining only after descendant replacement following selective shutdown in stem cells, would reject the mechanism.
Stage of verification
- Hypothesis published2026-09-30
- Indirect evidenceAssessed at 4 of 10
- Direct testAwaited
Map of the hypothesis
Hover over an icon or tap it to see its name.
Where in the body
Ageing mechanism
Lens
Kind of knowledge gap
A double ring marks the main placement where a group contains several values.
Target map
Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

Signalling molecule
Interleukin-6
A secreted signalling molecule
Where this hypothesis actsSecreted by hematopoietic stem cells with inflammatory memory during ageing, between infection episodes
Hypotheses on this target 2
Lower level
Synthesis suppression1
Neutralisation1
Supplementation
Accelerated excretion

What is proposed
Synthesis suppression
Suppress interleukin-6 synthesis and secretion in hematopoietic stem cells
With whatControlled genetic model
HowInducible restriction of expression specifically in stem cells after memory formation, while preserving descendants' protective memory
Possible result
Possible reduction in sustained systemic exposure and lung and kidney damage before mature myeloid cell turnover
From the recordПосле формирования памяти ограниченное стволовыми клетками выключение синтеза интерлейкина-6 снижает его межэпизодный уровень

Immune response
Antimicrobial memory
An inherited cellular programme that supports rapid destruction of microorganisms
Where this hypothesis actsDescendants of hematopoietic stem cells with inflammatory memory, during repeated infection episodes
Hypotheses on this target 2
Inhibition
Activation
Function preservation2
Clearance restoration
Immunosuppression
Feedback restoration
Rhythm restoration

What is proposed
Function preservation
Preserve the descendants' protective antimicrobial memory
With whatNot stated in the record
HowRestrict interleukin-6 suppression to stem cells while retaining mature myeloid cell abundance, chromatin state and early antimicrobial activity
Possible result
Possible preservation of rapid antimicrobial protection while chronic organ damage decreases
From the recordБыстрая противоинфекционная защита обеспечивается отдельной, наследуемой потомками программой уничтожения микроорганизмов.
All targets of the lab
Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.
Solid and named: the targets of this hypothesis
Explore in depth
The logic
The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.
A lasting memory of infection might preserve rapid protection while also keeping organs exposed to damaging inflammation. The unexpected move is to assign these effects to different cells: a small population of blood-forming stem cells, which produce new blood cells, would supply the damaging signal, while their descendants would carry protection. This is a proposal generated by the pipeline, not a measured separation of those functions.
- Prior inflammation leaves lasting changes in blood-forming stem cells.
- The changed stem cells are proposed to release interleukin-6 continuously between infection episodes.
- During aging, release from this small population is proposed to become sufficient to sustain damage in several organs.
- Stem-cell descendants are proposed to inherit a separate program for rapidly killing microbes.
- Stopping interleukin-6 production specifically in stem cells is predicted to reduce the continuing signal and organ damage before existing descendants are replaced.
- Restoring the measured normal rate of interleukin-6 delivery is predicted to bring the damage back.
A workshop keeps producing trained repair crews while its own alarm rings continuously and disrupts the neighborhood. Silencing the workshop's alarm could end the disturbance without removing the crews' skills.
Where the picture breaks: The picture assumes that the alarm and the crews' skills operate independently. That independence, and whether such a small workshop can produce enough disturbance, are precisely what the biological proposal still has to establish.
- Master questionstep 01 of 04
Aging processes may reinforce one another, so changing a shared cause could benefit several body systems at once.
Rests on: The goal is to find a single intervention with benefits across several processes involved in aging.
AssumptionThe starting premise assumes that a shared causal link can be targeted to produce benefits across multiple systems. The supplied material does not establish such a target.
- Goal pillarstep 02 of 04
Restoring function across the body should come with fewer harmful consequences later.
Rests on: The preceding goal seeks benefits across several systems, but does not describe delayed harm caused by restoration.
LeapThe chain does not supply the connection between targeting a shared cause of aging and limiting a delayed cost of restoration, or identify the restoration and cost involved.
- Gap questionstep 03 of 04
Lasting changes left by inflammation in blood-forming stem cells might contain separable programs for chronic damage and rapid infection defense. Changing those cellular changes and the surrounding tissue independently before repeated infections could help distinguish their contributions.
Rests on: The previous stage calls for limiting delayed harm, but does not identify remembered inflammation in blood-forming stem cells as its cause.
LeapThe missing connection is why this particular cellular memory and tissue environment account for the delayed cost named in the preceding stage. The supplied sources address related immune memory, but do not establish that connection.
- Hypothesisstep 04 of 04
Blood-forming stem cells with lasting changes from inflammation are proposed to release enough interleukin-6 to sustain damage across organs during aging. Their descendants would inherit a separate infection-fighting program, allowing the damaging release to be stopped without erasing protection.S5S6S7
Rests on: The preceding question supplies the distinction between damaging and protective memory. The endpoint adds a proposed cellular division: stem cells provide the continuing damaging signal, and descendants provide rapid defense. JCI Insight (2026, S5) reports that rare changes in chromatin, the packaging of genetic material that helps regulate gene activity, persist across stages of blood-cell development after infection. This supports inheritance of some cellular changes, but does not establish the proposed interleukin-6 source, organ damage, or preservation of protection after the intervention. Frontiers in Immunology (2025, S6) reviews findings that blood-forming stem cells are required for lasting trained immunity, a persistent change in the response of the body's early immune defenses. It does not establish direct interleukin-6 release by those cells or the proposed separation of damage and protection. Advanced Science (2026, S7) reports improved defense against a later bacterial infection following transfer of a population enriched for early blood-forming cells in mice. It does not establish the proposed mechanism during aging or test selective interruption of stem-cell interleukin-6.
AssumptionThe proposal assumes that the rare stem-cell population supplies a quantitatively sufficient, continuing interleukin-6 signal and that descendants retain protective function independently of that signal. These are the mechanism's stated premises, not established findings.
What is carried, and what is not. Three component links have partial support in the cited material: persistence of immune memory involving stem cells, inheritance of some changes in genetic packaging, and enhanced defense against a later infection. None of those sources establishes the sequence from direct stem-cell interleukin-6 release to sustained organ damage, followed by reduced damage with protection preserved when that release stops.
Where the reasoning is carried by something unstated · 4
- Master question. The starting premise assumes that a shared causal link can be targeted to produce benefits across multiple systems. The supplied material does not establish such a target.
- Goal pillar. The chain does not supply the connection between targeting a shared cause of aging and limiting a delayed cost of restoration, or identify the restoration and cost involved. Establish the missing link before relying on this step.
- Gap question. The missing connection is why this particular cellular memory and tissue environment account for the delayed cost named in the preceding stage. The supplied sources address related immune memory, but do not establish that connection. Establish the missing link before relying on this step.
- Hypothesis. The proposal assumes that the rare stem-cell population supplies a quantitatively sufficient, continuing interleukin-6 signal and that descendants retain protective function independently of that signal. These are the mechanism's stated premises, not established findings.
How a result here could mislead · 3
- Reduced damage could be credited to direct stem-cell release even if the intervention also changes descendants, blood-cell production, or the local tissue that supports stem cells. What closes it: The intervention's restriction to stem cells must be demonstrated. The proposed tracking of descendants must establish that damage changes before their replacement, while their numbers, genetic packaging, and early infection-fighting activity remain comparable with controls; changes in blood-cell production and the supporting tissue must be measured separately.
- A fall in circulating interleukin-6 could be mistaken for proof that stem cells directly supplied the damaging amount. It could instead reflect a change in release from other cells, and restoring the signal could restore damage without identifying its original source. What closes it: Measurements of release by individual stem cells must be combined with their abundance to establish whether their total output can account for the proposed exposure. The restoration experiment must reproduce the measured physiological delivery rate, rather than an arbitrary amount.
- An absence of reduced damage could be read as rejection of the mechanism even if interleukin-6 production was not sufficiently stopped. Conversely, comparable early infection-fighting activity could be read as proof that protection remains intact throughout repeated infections. What closes it: Loss of the targeted release must be verified before interpreting a negative result. Preservation of protection must also be assessed through the repeated infection episodes specified by the question; the supplied material gives no fixed criterion for sufficient suppression or preserved protection, so those criteria must be set before results are interpreted.
What would make this wrong. The central claim would fail if the stem-cell population does not release enough interleukin-6 to account for the proposed continuing exposure, or if reduced damage appears only after its descendants are replaced. Verified selective suppression that leaves the continuing signal and organ damage unchanged would also contradict the damaging-source claim; loss of infection defense despite unchanged descendants and supporting tissue would contradict the proposed independence of protection.
What it would change. If the mechanism held, one continuing signal from a small cell population could connect damage in several organs while remaining separable from useful infection memory. Work toward a shared intervention against aging would then need to distinguish the cells supplying chronic harm from the descendants carrying protection, rather than treating all remembered inflammation as one target. Even a successful test would not by itself establish longer life, benefits beyond the measured organs, or applicability to humans; the endpoint does not specify the species or duration of testing.
Sources read · 4
Rare epigenetic alterations are conserved across hematopoietic differentiation stages after mycobacterial infection. · JCI insight · 2026
“Overall, we provide one of the first studies to our knowledge to determine whether chromatin modifications induced in HSPCs are conserved through stages of myeloid differentiation.”
Does not settle: Источник и роль интерлейкина-6, хроническое повреждение органов, системное воздействие при старении, избирательное прекращение секреции в стволовых клетках и сохранение противоинфекционной защиты после такого вмешательства.
Advocating the role of trained immunity in the pathogenesis of ME/CFS: a mini review. · Frontiers in immunology · 2025
“However, more recent findings indicate that hematopoietic stem cells in the bone marrow are required for long-term persistence of trained immunity.”
Does not settle: It does not establish direct IL-6 secretion by hematopoietic stem cells, organ damage caused by such secretion, an aging-associated source contribution, or that selectively stopping stem-cell IL-6 preserves antimicrobial memory in descendants.
BCG HSP70 Reprograms Macrophages via Central Trained Immunity to Suppress Prostate Cancer. · 2026
“Together, these data indicated that pre‐stimulation with Dnak induces persistent functional changes in LSK cells, conferring a significantly improved response against secondary bacterial infection.”
Does not settle: Источник не исследует интерлейкин-6, хроническое повреждение органов, старение или избирательное прекращение секреции в стволовых клетках. Он показывает противоинфекционную защиту после переноса клеток LSK в модели мышей.
Mesenchymal Stromal Cells Facilitate Neutrophil-Trained Immunity by Reprogramming Hematopoietic Stem Cells. · Journal of innate immunity · 2023
“Despite an increased number of neutrophils, infected chimeras transplanted with CpG-BM had lower levels of IL-6 and IL-17A compared to both infected chimeras transplanted with MSC-BM and Ctrl-BM ( i), suggesting that the augmented granulopoiesis was not arising from a persistent, dysregulated cytokine response”
Does not settle: Источник интерлейкина-6, прямой секреторный вклад кроветворных стволовых клеток, хроническое повреждение органов при старении и эффект избирательного прекращения секреции интерлейкина-6 в этих клетках. Работа описывает мышиные костномозговые химеры и ответ на инфекцию P. aeruginosa.
The gap this hypothesis explains
Something is claimed here, but it rests on evidence too thin to carry weight.
Can changing blood-forming stem-cell memory separately from its surroundings reduce lasting damage while preserving protection against repeated infections?
Original wording · exactly as the pipeline generated it
Можно ли причинно разделить воспалительную память кроветворных стволовых клеток на программу хронического повреждения и программу быстрой защиты, если независимо изменять клеточную память и тканевое окружение перед повторными инфекционными эпизодами?
What this question is asking
The question concerns lasting changes in blood-forming stem cells after inflammation, and whether their harmful and protective effects can be separated. It asks what happens when those lasting changes and the surrounding tissue are altered independently before repeated infections. The comparison is whether lasting damage can decrease while the body still limits the amount of infection in the first hours and days and retains that ability across later episodes. It assumes that cell memory and the surrounding tissue could contribute to both outcomes, but the supplied sources do not establish two distinct programs that can be independently controlled.
- Blood-forming stem cells
- Cells that can maintain their own population and produce the different types of blood cells, including immune cells. Lasting changes in these cells are the proposed starting point of the question.
- Progenitor cells
- Descendants of stem cells that produce a more restricted range of cell types. S2 discusses them together with blood-forming stem cells, so its statement is not limited to stem cells alone.
- Inflammation
- A collection of bodily responses to infection or injury. In this question, it is the earlier condition proposed to leave lasting changes in blood-forming cells; inflammation and lasting tissue damage are not interchangeable measurements.
- Cell memory or inflammatory memory
- A lasting alteration in how a cell responds after an earlier exposure, rather than conscious memory. Here it names a proposed persistent state, not an already identified single mechanism with proven harmful and protective components.
- Cellular program
- A coordinated pattern of activity within cells. Calling damage and protection separate programs does not establish that they have distinct causes or can be independently switched off.
- Tissue surroundings
- Nearby cells and the local conditions and signals that influence a cell. For blood-forming stem cells, the supplied sources discuss supporting surroundings within bone marrow.
- Bone marrow
- Tissue inside bones where blood cells are produced. It contains both blood-forming cells and cells that support and regulate them.
- Mesenchymal stromal cells
- A class of supporting cells that can release signals affecting other cells. In S7, their released signals are reported to leave blood-forming stem cells prepared for a later enhanced response.
- Emergency granulopoiesis
- An increased production of granulocytes, a group of immune cells, in response to urgent demand. This is the response described in S7; increased cell production alone does not establish reduced infection or reduced lasting damage.
- Chimeric mouse model and transplantation
- A research setting in which a mouse contains introduced cells from another source; transplantation is the transfer of those cells. S7 reports a response months after that transfer, which is a different timescale from measuring infection control during its first hours and days.
- Bacillus Calmette–Guérin vaccination
- The vaccination examined in S8 for its capacity to protect against viral disease. The supplied quote describes that protection as dependent on the disease process and tissues involved.
- Cellular metabolism and regulation of gene activity
- Cellular metabolism comprises the chemical processes through which cells obtain and use materials and energy. Regulation of gene activity controls how cells use their genetic instructions; S2 reports changes in both processes, without establishing their effects on repeated infections.
- Programmed cell death
- A regulated process through which a cell is eliminated. S3 discusses its control alongside cell division, rather than directly measuring the damage-versus-protection distinction in the question.
- Causal separation
- Distinguishing what each factor actually produces, rather than merely observing that factors change together. Here the factors are lasting states within blood-forming stem cells and influences from their surroundings.
- Chronic damage and protective capacity
- Chronic damage means continuing or lasting injury; protective capacity means the ability to limit infection, including during later episodes. They are outcomes requiring defined measurements, and the supplied material provides no numerical boundaries for either.
Inflammatory memory in blood-forming stem cells and signals from their tissue surroundings contribute to chronic damage and rapid protection as potentially separable programs.
Blood-forming stem cells produce blood and immune cells, while nearby supporting cells supply signals that influence their behavior. The assumption is that lasting changes within the stem cells and signals from those surroundings help determine both continuing injury and rapid defense against infection. If that holds, separating their contributions could explain whether reducing injury also removes protection.
S7 supports a narrower claim: signals released by supporting cells can leave blood-forming stem cells prepared for an enhanced response months after transplantation in mice. S2 reports changes in both blood-forming cells and supporting cells in diabetes, and S3 describes regulation by mechanisms inside stem cells together with signals from their surroundings. These findings do not establish that inflammatory memory causes both chronic damage and rapid protection, that these are distinct programs, or that their contributions have been independently separated before repeated infections.S2S3S7
The same question asked without the part nothing read establishes:
- Does independently changing lasting states in blood-forming stem cells and their surroundings affect chronic damage differently from early protection across repeated infections?
- What do lasting changes within blood-forming stem cells and signals from their surroundings each contribute to damage and protection during repeated infections?
- Damage falls and protection remains Under the question's proposed mechanism, a change would reduce the contribution to lasting injury while preserving early control of infection across later episodes. This would support functional separation under the conditions examined, although it would not by itself establish two distinct internal programs.
- Damage and protection fall together The change would reduce lasting injury but also weaken early control of infection or the ability to respond to later episodes. The apparent benefit from reduced damage would therefore come with a loss of defense; this outcome alone would not prove that a single internal program causes both effects.
- The outcome depends on the surroundings The same lasting cell state would produce different outcomes in different tissue surroundings. Protection or damage could then not be attributed to cell memory alone, and an effect observed in one setting would not establish the same tradeoff in another.
In the mechanism proposed by the question, an earlier inflammatory episode changes blood-forming stem cells, which can then change the supply or behavior of cells involved in later defenses. Signals from surrounding tissue could also influence these responses, making it difficult to attribute an outcome to memory inside the cells alone. If the same lasting change supports both damage and protection, removing it could reduce damage while weakening early control of infection. If those effects are separable, reducing damage would not necessarily require losing protection, but that separation is not demonstrated in the supplied evidence.
Узлы RL-1 описывают память предшественников и тканевых лимфоцитов; измерения RL-2 отслеживают состояния, но разделимость повреждения и защиты экспериментально не установлена.
После снижения воспаления инфекционная нагрузка ограничивается в первые часы и сутки; повторные эпизоды сохраняют защитный резерв в заданных границах.
Неизвестно, устраняет ли изменение памяти общий источник повреждения или одновременно расходует необходимый защитный резерв; причинность клеточной программы и окружения остаётся неразделённой.
The mechanism it proposes
The engine's own statement of the hypothesis, in full.
Хроническое повреждение поддерживается прямой секрецией интерлейкина-6 кроветворными стволовыми клетками с воспалительной памятью. Предполагается, что при старении их небольшой пул становится существенным источником длительного системного воздействия. Быстрая противоинфекционная защита обеспечивается отдельной, наследуемой потомками программой уничтожения микроорганизмов. Поэтому избирательное прекращение секреции интерлейкина-6 в стволовых клетках должно уменьшить повреждение нескольких органов при сохранении защитной памяти их потомков. Это разделение источника хронического воздействия и носителей быстрой защиты делает полное стирание памяти избыточным.
Testing and possible results
The prediction that would tell it apart
A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.
После формирования памяти ограниченное стволовыми клетками выключение синтеза интерлейкина-6 снижает его межэпизодный уровень и последующее повреждение лёгких и почек раньше обновления зрелых миелоидных клеток. Численность, состояние хроматина и ранняя противомикробная активность этих клеток остаются сопоставимыми с контролем. Восстановление измеренного физиологического потока интерлейкина-6 возвращает повреждение. Отсутствие достаточного потока из стволовых клеток или появление эффекта только после смены потомков опровергает центральное утверждение.
States a measurable outcome; comparing rivals needs more conditions. The prediction specifies directional changes, timing relative to cell turnover, control comparisons, restoration of damage, and explicit rejection conditions. No rival prediction is supplied. Only a bench experiment would settle it.
What testing it would take
The engine's own read on whether this is testable with methods that already exist.
Возможны индуцируемое ограничение экспрессии в стволовых клетках, прослеживание потомков и измерение секреции отдельных клеток. Главная трудность состоит в доказательстве специфичности воздействия и количественной достаточности секреции редкого пула. Эксперимент должен отдельно контролировать изменения костномозговой ниши и образования клеток крови.
Other explanations
Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.
После формирования памяти ограниченное стволовыми клетками выключение синтеза интерлейкина-6 снижает его межэпизодный уровень и последующее повреждение лёгких и почек раньше обновления зрелых миелоидных клеток. Численность, состояние хроматина и ранняя противомикробная активность этих клеток остаются сопоставимыми с контролем. Восстановление измеренного физиологического потока интерлейкина-6 возвращает повреждение. Отсутствие достаточного потока из стволовых клеток или появление эффекта только после смены потомков опровергает центральное утверждение.
- What would separate them
Molecular crowding may shift enzyme forms to preserve rapid antimicrobial defense predicts: При одинаковых количестве фермента, составе клеток и состоянии хроматина обратимое изменение доли объёма, занятого макромолекулами, меняет образование восстановительного эквивалента и раннее уничтожение микроорганизмов. Эффект возникает до изменения транскрипции. В бесклеточной реконструкции воспроизводятся направление и величина сдвига равновесия ферментных форм. Если влияние исчезает после контроля осмолярности, кислотности и вязкости либо сопровождается только изменением транскрипции, гипотеза исключённого объёма теряет поддержку.
- What would separate them
Queuosine modification may separate antimicrobial protection from inflammatory damage predicts: При одинаковом количестве матричной РНК изменение квеозиновой модификации меняет отношение синтеза выбранных защитных и повреждающих белков. Зависимость защитного белка от модификации исчезает после синонимической замены чувствительных кодонов при сохранении его аминокислотной последовательности и сопоставимых количества и стабильности матричной РНК. Такая замена восстанавливает раннюю защитную функцию после ослабления воспалительной памяти. Сохранение эффекта после замены кодонов либо отсутствие различий между защитным и повреждающим наборами белков опровергает предложенное разделение.
- What would separate them
Carbamylation may turn protective cathelicidins into tissue-damaging molecules predicts: При одинаковой секреции кателицидина и одинаковой ранней инфекционной нагрузке повреждение ткани определяется долей конкретных карбамилированных форм. Химически определённая N-концевая модификация человеческого LL-37 повышает повреждение клеток хозяина при сохранении бактерицидного эффекта в подходящей модели. Ограничение образования этой формы уменьшает повреждение, а её добавление в измеренной физиологической концентрации возвращает его. Отсутствие достаточного количества модифицированного пептида in vivo или эффекта его избирательной замены опровергает механизм.
Why this is not the mainstream account
The engine is asked to say what its hypothesis would overturn and what would surprise a specialist. This is its answer.
Zhao и соавторы показали интенсивную секрецию различных цитокинов короткоживущими стволовыми клетками и мультипотентными предшественниками. Неожиданная секреторная активность служит основанием для гипотезы, однако её перенос на долгоживущие клетки старого организма требует проверки. [Первичное исследование](https://pubmed.ncbi.nlm.nih.gov/24561084/).
Биология центральной памяти врождённого иммунитета. Пересмотру подлежал бы учебный раздел «Передача памяти кроветворных стволовых клеток через дифференцированных потомков»: для хронического многосистемного повреждения потребовалось бы признать ведущую прямую эндокринную функцию самих стволовых клеток.
Выключение одного секретируемого продукта исключительно в редких долгоживущих стволовых клетках быстро прекращает повреждение удалённых органов, хотя воспалительная память и функциональная активность уже существующих зрелых потомков сохраняются.
Адресный поиск выявил известную секрецию цитокинов предшественниками, но не установил существование обзора, утверждающего количественно ведущую прямую эндокринную роль долгоживущих стволовых клеток в повреждении стареющих органов. Это ограниченная проверка новизны, а не доказательство отсутствия публикаций; статус HERETICAL предварительный.
What stands behind it
Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.
This hypothesis states no figure and cites no study, so there is nothing here to trace.
What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.
0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.